Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
05/1991
05/02/1991WO1991005867A1 Erythropoietin isoforms
05/02/1991WO1991005866A1 Novel expression systems utilizing bacteriophage t7 promoters and gene sequences
05/02/1991WO1991005864A1 Production of genetically-engineered vaccines for aids and other retroviral diseases
05/02/1991WO1991005863A1 Recombinant growth factors
05/02/1991WO1991005862A1 cDNA FRAGMENT CODING THE ALPHA INTERFERON RECEPTOR GENE AND PROCESS FOR THE PREPARATION OF A CORRESPONDING PROTEIN
05/02/1991WO1991005855A1 Modified biological material
05/02/1991WO1991005853A1 Growth hormone antagonists
05/02/1991WO1991005803A1 Recombinant human thrombomodulin
05/02/1991WO1991005802A1 Osteogenic devices
05/02/1991WO1991005798A1 Compositions and methods for treating or preventing infections in canine and feline animals
05/02/1991WO1991005795A1 Stem cell factor
05/02/1991WO1991005519A1 Array-type multiple cell injector
05/02/1991WO1990013306A3 Small polypeptides
05/02/1991EP0425082A1 Bordetella vaccines
05/02/1991EP0425004A2 Genetic manipulations with recombinant DNA comprising sequences derived from RNA virus
05/02/1991EP0424990A1 The manufacture and expression of large structural genes
05/02/1991EP0424771A1 Plasmids and hosts for the expression of INA protein (ice nucleating protein)
05/02/1991EP0424748A1 Synthetic envelope peptides of HTLV-I
05/02/1991EP0424688A2 Synergistic method for host cell transformation
05/02/1991EP0424519A1 Antigenes of the envelope transmembrane glycoprotein of a human retrovirus of the hiv-2 type, and antigens presenting with them an immunological relationship.
05/02/1991EP0424484A1 Novel bacteriocin compositions for use as enhanced broad range bactericides and methods of preventing and treating microbial infection.
05/02/1991EP0424459A1 Dna encoding human monoamine oxidase type a
05/02/1991EP0424437A1 Recombinant mycobacterial expression vehicles and uses therefor
05/02/1991EP0424429A1 New expression vectors
05/02/1991EP0424413A1 Dna segment, plasmid containing this segment, transformed bacteria and transformed plant material
05/02/1991EP0214232B1 Polypeptides complementary to peptides or proteins having an amino acid sequence or nucleotide coding sequence at least partially known and methods of design therefor
05/02/1991EP0205564B1 Method for the production of erythropoietin
05/02/1991DE3935572A1 Verfahren zur peptidsynthese und traeger dafuer A method for peptide synthesis and carrier therefor
05/02/1991CA2067235A1 Modified biological material
05/02/1991CA2042577A1 Osteogenic devices
05/01/1991WO1991006652A1 Outer membrane protein p1 and peptides of haemophilus influenzae type b
05/01/1991WO1991006651A1 Gene conferring salt tolerance
05/01/1991WO1991006637A1 Subtilisin mutants
05/01/1991WO1991006628A1 Expression of bacterial hemoglobin and enhancement of expression of cloned and native products in streptomyces
05/01/1991WO1991006318A1 The design and construction of non-infectious human retroviral mutants deficient in genomic rna
05/01/1991CN1051058A Cloning and expression of microbial phytase
05/01/1991CA2072115A1 Expression of bacterial hemoglobin and enhancement of expression of cloned and native products in streptomyces
05/01/1991CA2070395A1 Gene conferring salt tolerance
04/1991
04/30/1991US5012040 Produces sclareol
04/30/1991US5011912 Calcium-dependent affinity for selected peptide terminal sequence
04/30/1991US5011795 Human tPA production using vectors coding for DHFR protein
04/30/1991US5011776 Shuttle vector, utilizing the E. coli asparagine synthetase gene, and capable of dominant transfection and amplification in animal cells
04/30/1991CA2001756A1 New human lymphotoxin n-end deletion mutant
04/28/1991WO1991006650A1 C1 inhibitor muteins and uses thereof
04/28/1991WO1991006572A1 Diagnosis of glomerulonephritis
04/28/1991WO1991006320A1 Compositions containing plant-produced glycopolypeptide multimers, multimeric proteins, and their use
04/28/1991CA2071871A1 C1 inhibitor muteins and uses thereof
04/28/1991CA2071530A1 Diagnosis of glomerulonephritis
04/28/1991CA2071502A1 Compositions containing plant-produced glycopolypeptide multimers, multimeric proteins, and their use
04/28/1991CA2028517A1 Enhancement of porcine somatotropin activity
04/26/1991WO1991006677A1 Receptor infection assay
04/26/1991WO1991006673A1 ISOLATING OF STRAINS OF SACCHAROMYCES CEREVISIAE HAVING ALTERED Nα-ACETYLTRANSFERASE ACTIVITY
04/26/1991WO1991006636A1 Identification of methionine n-alpha-acetyltransferase
04/26/1991CA2071486A1 Isolating of strains of saccharomyces cerevisiae having altered n.alpha.-acetyltransferase activity
04/26/1991CA2067757A1 Identification of methionine n-alpha-acetyltransferase
04/26/1991CA2067216A1 Receptor infection assay
04/26/1991CA2027852A1 Food additives
04/25/1991WO1991006647A1 Gastrin releasing peptide receptor
04/25/1991WO1991006646A1 Solubilization and purification of the gastrin releasing peptide receptor
04/25/1991WO1991006635A1 Method for producing secretable glycosyltransferases and other golgi processing enzymes
04/25/1991CA2069965A1 Solubilization and purification of the gastrin releasing peptide receptor
04/25/1991CA2067821A1 Infective drug delivery system using recombinant retroviral vectors
04/25/1991CA2067766A1 Gastrin releasing peptide receptor
04/24/1991EP0424351A2 Modified heparin cofactor II
04/24/1991EP0424117A1 Yeast promoter
04/24/1991EP0424047A1 Tissue culture method for transformation of plant cells
04/24/1991EP0424044A1 Transgenic fowl expressing bovine growth hormone
04/24/1991EP0424027A1 Vectors for generating transgenic fowl
04/24/1991EP0423980A1 Stem cell factor
04/24/1991EP0423890A2 Use of oxidoreductases in bleaching and/or detergent compositions and their preparation by microorganisms engineered by recombinant DNA technology
04/24/1991EP0423869A1 Infectious bronchitis virus vaccine
04/24/1991EP0423845A1 A synthetic gene encoding gamma-interferon
04/24/1991EP0423839A2 Polynucleotides and probes useful in solution phase nucleic acid sandwich assay
04/24/1991EP0423317A1 Invasive microorganisms
04/24/1991EP0423302A1 Application of novel dna fragments as a coding sequence for a signal peptide for the secretion of mature proteins by recombinant yeast, expression cassettes, transformed yeasts and corresponding process for the preparation of proteins.
04/24/1991EP0423264A1 Recombinant cold shock protein, production and use in agriculture
04/24/1991EP0423252A1 Tumour necrosis factor muteins
04/24/1991EP0423224A1 Leader sequence inducing a post-translational modification of polypeptides in bacteria, and gene therefor
04/24/1991EP0423193A1 A method of treating diseases caused by immunodeficiency states by administering human neutrophil chemotactic factor to human
04/24/1991CN1050899A Novel entities for cancer therapy
04/24/1991CA2028172A1 Synthetic envelope peptides of htlv-i
04/23/1991US5010183 Process for purifying DNA and RNA using cationic detergents
04/23/1991US5010182 DNA constructs containing a Kluyveromyces alpha factor leader sequence for directing secretion of heterologous polypeptides
04/23/1991US5010015 Plasmid capable of multiplying in bacillus, regulation and secretion signal sequences of the amylase gene and the dna sequence encoding for the protein or polypeptide
04/23/1991US5010011 Bovine placental lactogen gene
04/23/1991US5010010 DNA sequence encoding Saccharomyces mating factor alpha 1 linked to human parathyroid hormone stably transforms yeast cell to express and secrete the hormone
04/23/1991US5010003 Use of yeast homologous signals to secrete heterologous proteins
04/23/1991US5010002 Human t-PA production using vectors coding DHFR protein
04/23/1991US5010001 Growing excherichia with expression vector containing gene encoding for endotoxin; isolation of bacillus delta-endotoxin
04/23/1991US5010000 Method for the preparation of a selected protein or a part thereof in Bacillus strain bacteria
04/23/1991CA1283375C Method of biosynthesis and cells therefor
04/23/1991CA1283374C Recombinant dna expression vectors and method for gene expression
04/23/1991CA1283373C Use of the gal 1 yeast promoter
04/21/1991WO1991005865A1 Dna, constructs, cells and plants derived therefrom
04/21/1991WO1991005805A1 MONOCLONAL ANTIBODY SPECIFIC FOR IgA RECEPTOR
04/21/1991CA2028082A1 Modified heparin cofactor ii
04/21/1991CA2028045A1 Infectious bronchitis virus vaccine
04/20/1991WO1991005792A1 A dna fragment encoding a rubber polymerase and its related products
04/20/1991CA2042359A1 Dna fragment encoding a rubber polymerase and its related products
04/19/1991WO1991005794A1 Stable mammalian cell lines that express aromatase